289032-37-7

Basic information

• Product Name: 5-(4-BIPHENYLYL)PENTANAL
• Synonyms: 5-(4-BIPHENYLYL)PENTANAL
• CAS NO: 289032-37-7
• Molecular Formula: C17H18O
• Molecular Weight: 238.32
• Mol File: 289032-37-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-(4-BIPHENYLYL)PENTANAL(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-BIPHENYLYL)PENTANAL(289032-37-7)
• EPA Substance Registry System: 5-(4-BIPHENYLYL)PENTANAL(289032-37-7)

Safety Data

• Hazardous Substances Data: 289032-37-7(Hazardous Substances Data)

Usage

Also known as

benzhydryl valeraldehyde

Classification

aromatic aldehyde

Mains uses

fragrance and flavoring agent, production of synthetic flavors and perfumes

Odor

strong, sweet, floral, jasmine-like

Additional uses

reagent in organic synthesis, formulation of various chemical products

Regulation

due to potential health and environmental hazards

Upstream product

• 120756-57-2 4-(5-hydroxypentyl)-1,1'-biphenyl 
• 3218-36-8 4-Phenylbenzaldehyde 
• 16913-50-1 (2E,4E)-ethyl 5-(biphenyl-4-yl)penta-2,4-dienoate 
• 1155663-08-3 ethyl 5-(biphenyl-4-yl)pentanoate 

Relevant articles and documents

Rhodium-Catalyzed Remote C(sp3)?H Borylation of Silyl Enol Ethers

A rhodium-catalyzed remote C(sp3)?H borylation of silyl enol ethers (SEEs, E/Z mixtures) by alkene isomerization and hydroboration is reported. The reaction exhibits mild reaction conditions and excellent functional-group tolerance. This method is compatible with an array of SEEs, including linear and branched SEEs derived from aldehydes and ketones, and provides direct access to a broad range of structurally diverse 1,n-borylethers in excellent regioselectivities and good yields. These compounds are precursors to various valuable chemicals, such as 1,n-diols and aminoalcohols.

DESIGN AND SYNTHESIS OF OPTIMIZED LIGANDS FOR PPAR

This invention provides new chemical entities useful for treating a variety of clinical disorders including those that areinfluenced by the activity of peroxisome proliferator activated receptors (PPAR). The structures of the compounds and methods to design, make and use the compounds are provided. Compounds and methods for administering therapeutic compositions comprising the compounds in cases of the disease psoriasis are provided. An exemplary compound having the formula compound is 5-adamantan-2-yl-pentanoic acid {2-[4-(2,4-dioxo-thiazolidin-5-yl-methyl)-phenoxy]-ethyl}-methyl-amide is provided.